Filed: 11/10/2022ACC: 0001567619-22-019570
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $222.4K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$222.4K
Total AUM (reported)
71.01M
Total Shares
Allocation by class
COM$150.4K67.6%
SPONSORED ADS$43.1K19.4%
COM NEW$19.7K8.8%
SPONS ADR NEW$9.3K4.2%
Portfolio Concentration
Top 3$111.9K50.3%
4–10$83.3K37.5%
11–25$27.2K12.2%
Top 3 weight
50.3%
Top 10 weight
87.8%
Voting Authority Distribution
Total shares with voting rights: 71.01M
Sole
Full voting authority
71.01M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
AMRYT PHARMA PLC - SPNR ADR
SOLEShares6.23M
TypeSH
Market value$43.1K
19.37%
Sole
6.23M
Shared
0.00
None
0.00
QUIDELORTHO CORP
SOLEShares501.63K
TypeSH
Market value$35.9K
16.12%
Sole
501.63K
Shared
0.00
None
0.00
CTI BIOPHARMA CORP
SOLEShares5.67M
TypeSH
Market value$33.0K
14.83%
Sole
5.67M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares12.93M
TypeSH
Market value$20.2K
9.07%
Sole
12.93M
Shared
0.00
None
0.00
APOLLO ENDOSURGERY INC
SOLEShares2.83M
TypeSH
Market value$15.6K
7.02%
Sole
2.83M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares5M
TypeSH
Market value$12.2K
5.46%
Sole
5M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.12M
TypeSH
Market value$9.4K
4.21%
Sole
1.12M
Shared
0.00
None
0.00
AMARIN CORP PLC -ADR
SOLEShares8.55M
TypeSH
Market value$9.3K
4.19%
Sole
8.55M
Shared
0.00
None
0.00
LIGAND PHARMACEUTICALS
SOLEShares99.56K
TypeSH
Market value$8.6K
3.85%
Sole
99.56K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares2.97M
TypeSH
Market value$8.1K
3.66%
Sole
2.97M
Shared
0.00
None
0.00
OPTINOSE INC
SOLEShares2M
TypeSH
Market value$7.3K
3.29%
Sole
2M
Shared
0.00
None
0.00
AFFIMED NV
SOLEShares1.98M
TypeSH
Market value$4.1K
1.83%
Sole
1.98M
Shared
0.00
None
0.00
EXAGEN INC
SOLEShares1.27M
TypeSH
Market value$3.4K
1.54%
Sole
1.27M
Shared
0.00
None
0.00
CONFORMIS INC
SOLEShares17.30M
TypeSH
Market value$3.3K
1.49%
Sole
17.30M
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares1.54M
TypeSH
Market value$2.8K
1.27%
Sole
1.54M
Shared
0.00
None
0.00
ATYR PHARMA INC
SOLEShares600.98K
TypeSH
Market value$1.8K
0.81%
Sole
600.98K
Shared
0.00
None
0.00
OPIANT PHARMACEUTICALS INC
SOLEShares152.28K
TypeSH
Market value$1.6K
0.74%
Sole
152.28K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares200K
TypeSH
Market value$1.6K
0.72%
Sole
200K
Shared
0.00
None
0.00
XOMA CORP
SOLEShares64.46K
TypeSH
Market value$1.2K
0.52%
Sole
64.46K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMRYT PHARMA PLC - SPNR ADRSOLE | SPONSORED ADS | 6.23M | SH | $43.1K 19.37% | 6.23M | 0.00 | 0.00 |
QUIDELORTHO CORPSOLE | COM | 501.63K | SH | $35.9K 16.12% | 501.63K | 0.00 | 0.00 |
CTI BIOPHARMA CORPSOLE | COM | 5.67M | SH | $33.0K 14.83% | 5.67M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 12.93M | SH | $20.2K 9.07% | 12.93M | 0.00 | 0.00 |
APOLLO ENDOSURGERY INCSOLE | COM | 2.83M | SH | $15.6K 7.02% | 2.83M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 5M | SH | $12.2K 5.46% | 5M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.12M | SH | $9.4K 4.21% | 1.12M | 0.00 | 0.00 |
AMARIN CORP PLC -ADRSOLE | SPONS ADR NEW | 8.55M | SH | $9.3K 4.19% | 8.55M | 0.00 | 0.00 |
LIGAND PHARMACEUTICALSSOLE | COM NEW | 99.56K | SH | $8.6K 3.85% | 99.56K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 2.97M | SH | $8.1K 3.66% | 2.97M | 0.00 | 0.00 |
OPTINOSE INCSOLE | COM | 2M | SH | $7.3K 3.29% | 2M | 0.00 | 0.00 |
AFFIMED NVSOLE | COM | 1.98M | SH | $4.1K 1.83% | 1.98M | 0.00 | 0.00 |
EXAGEN INCSOLE | COM | 1.27M | SH | $3.4K 1.54% | 1.27M | 0.00 | 0.00 |
CONFORMIS INCSOLE | COM | 17.30M | SH | $3.3K 1.49% | 17.30M | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 1.54M | SH | $2.8K 1.27% | 1.54M | 0.00 | 0.00 |
ATYR PHARMA INCSOLE | COM NEW | 600.98K | SH | $1.8K 0.81% | 600.98K | 0.00 | 0.00 |
OPIANT PHARMACEUTICALS INCSOLE | COM | 152.28K | SH | $1.6K 0.74% | 152.28K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 200K | SH | $1.6K 0.72% | 200K | 0.00 | 0.00 |
XOMA CORPSOLE | COM NEW | 64.46K | SH | $1.2K 0.52% | 64.46K | 0.00 | 0.00 |